A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 48/00 (2006.01) A61K 31/70 (2006.01) A61K 39/295 (2006.01) C07K 14/015 (2006.01) C07K 14/03 (2006.01) C07K 14/13 (2006.01) C07K 14/145 (2006.01) C07K 14/165 (2006.01)
Patent
CA 2260273
Vaccine formula against Canidae pathogens, comprising at least two vaccine valencies each comprising a plasmid integrating, so as to express it in vivo in the Canidae host cells, a gene with one canine pathogen valency, namely a Carre's disease virus CDV valency and a canine parvovirus CPV valency, the plasmids comprising, for each valency, one or more of the genes selected from the group consisting of HA and F for the Carre's disease virus and the VP2 gene for the canine parvovirus.
La formule de vaccin contre des pathogènes des canidés, comprenant au moins deux valences de vaccin comprenant chacune un plasmide intégrant de manière à l'exprimer in vivo dans les cellules hôtes du canidé, un gène d'une valence de pathogène canin, à savoir une valence du virus de la maladie de Carré CDV et une valence du parvovirus canin CPV, les plasmides comprenant, pour chaque valence, un ou plusieurs des gènes choisis parmi le groupe consistant en HA et F pour le virus de la maladie de Carré et le gène VP2 pour le parvovirus canin.
Audonnet Jean-Christophe
Bouchardon Annabelle
Riviere Michel
Merial
Smart & Biggar
LandOfFree
Polynucleotide vaccine formula against canine pathologies,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polynucleotide vaccine formula against canine pathologies,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polynucleotide vaccine formula against canine pathologies,... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1499079